Last updated: July 14, 2026
The table below summarizes Rhythm360's core capabilities and the metrics that matter most to multi-vendor practices weighing a switch in 2026.
| Capability | Rhythm360 Detail | 2026 Metric | Source / Context |
|---|---|---|---|
| Supported Manufacturers | Medtronic, Boston Scientific, Abbott, Biotronik, and others | All major OEMs in a single dashboard | RhythmScience platform documentation |
| AI Alert Triage | AI-powered filtering prioritizes clinically significant events and suppresses non-actionable noise | Up to 80% reduction in critical alert response times | RhythmScience platform outcomes |
| EHR Integration | Bi-directional; Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and others via HL7 | Integration setup in days to weeks | RhythmScience onboarding documentation |
| Billing Automation | Automated CPT code capture and documentation (93298, 93299, 99454, and others) | Up to 300% revenue increase | RhythmScience client outcomes |
| Data Transmissibility | Redundant data feeds, computer vision (OCR), and AI-powered extrapolation | Greater than 99.9% transmissibility | RhythmScience platform documentation |
| Scalability | Cloud-based SaaS; scales from solo EP clinics to large academic health systems | University of Chicago Medicine processed over 73,000 reports annually through Rhythm360 in 2025 | HMP Global white paper, UCM implementation |
| Mobile Access | HIPAA-compliant mobile app for transmission review, report signing, and care coordination | 24/7/365 access from any device | RhythmScience platform documentation |
Schedule a demo to see the full Rhythm360 dashboard in action.
Medtronic, Boston Scientific, Abbott, and Biotronik devices appear most consistently across universal monitoring studies. Microport has also entered the vendor-neutral ecosystem as device adoption grows internationally.
Rhythm360 supports all major OEM device families. This includes pacemakers, ICDs, implantable loop recorders (ILRs), CRT devices, CCM devices, and specialized sensors such as CardioMEMS pulmonary artery monitors. The platform combines direct API connections, HL7 feeds, XML parsing, and AI-assisted computer vision for unstructured PDF reports. This multi-pathway ingestion architecture drives the greater than 99.9% transmissibility rate, even when an OEM's server goes down.
Most active EP programs implant devices from more than one manufacturer, and these practices face the steepest administrative burden under fragmented portal workflows. Andrew Beaser, MD, Associate Professor of Medicine at University of Chicago Medicine, described pre-implementation multi-portal workflows as "a major challenge and incredibly difficult." Consolidating every supported manufacturer into one interface removes that burden directly, which sets up the next problem worth solving: alert overload.
Alert fatigue is a documented patient safety risk in high-volume CIED monitoring environments. Even with manufacturer-embedded AI algorithms, 32.9% of episodes from major OEM devices were non-actionable and 30.6% were indeterminate based on independent expert adjudication. Roughly two-thirds of raw transmissions may not require immediate clinical action. Without intelligent triage, every alert still competes for the same staff attention.
A JACC: Advances study evaluating an AI triage system reduced transmissions forwarded for review by 40% while achieving 99.1% sensitivity for clinically relevant events. Other recent research on AI triage for remote patient monitoring echoes this finding, showing high sensitivity for emergency events alongside reduced clinical triage time.
Rhythm360's AI-powered alert triage filters non-actionable transmissions and surfaces prioritized, clinically significant events. This cuts critical alert response times by up to 80% for practices using the platform. Andrew Beaser, MD, at UCM noted the shift in practice:
